These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34339395)

  • 1. Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq.
    Zhou R; Liang J; Chen Q; Tian H; Yang C; Liu C
    Aging (Albany NY); 2021 Aug; 13(15):19415-19441. PubMed ID: 34339395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer.
    Zhang P; Liu Z; Wang D; Li Y; Xing Y; Xiao Y
    Front Immunol; 2021; 12():724541. PubMed ID: 34512654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
    Liu L; Hu J; Wang Y; Sun T; Zhou X; Li X; Ma F
    Aging (Albany NY); 2020 Jun; 12(12):11967-11989. PubMed ID: 32570217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysis.
    Xiong Y; Yuan L; Xiong J; Xu H; Luo Y; Wang G; Ju L; Xiao Y; Wang X
    J Cell Mol Med; 2020 Feb; 24(3):2342-2355. PubMed ID: 31883309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: applying RNA-sequencing analysis on archived specimens.
    Sharron Lin X; Hu L; Sandy K; Correll M; Quackenbush J; Wu CL; Scott McDougal W
    Urol Oncol; 2014 Apr; 32(3):327-36. PubMed ID: 24055427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer.
    Zhang J; Huang Y; Tan X; Wang Z; Cheng R; Zhang S; Chen Y; Jiang F; Tan W; Deng X; Li F
    Int Immunopharmacol; 2024 Jul; 136():112184. PubMed ID: 38824904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
    Lai H; Cheng X; Liu Q; Luo W; Liu M; Zhang M; Miao J; Ji Z; Lin GN; Song W; Zhang L; Bo J; Yang G; Wang J; Gao WQ
    Int J Cancer; 2021 Dec; 149(12):2099-2115. PubMed ID: 34480339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinoma.
    Zhang C; He H; Hu X; Liu A; Huang D; Xu Y; Chen L; Xu D
    Aging (Albany NY); 2019 Nov; 11(22):10183-10202. PubMed ID: 31747386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Bao Z; Zhang W; Dong D
    Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma.
    Liu K; Gao R; Wu H; Wang Z; Han G
    J Cell Mol Med; 2021 May; 25(9):4260-4274. PubMed ID: 33759378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
    Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
    Gynecol Oncol; 2019 Dec; 155(3):499-507. PubMed ID: 31662204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer.
    Zhou R; Liang J; Tian H; Chen Q; Yang C; Liu C
    Dis Markers; 2021; 2021():1031906. PubMed ID: 34239619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
    Zhang C; Shen K; Zheng Y; Qi F; Luo J
    Cancer Med; 2020 Jan; 9(2):768-782. PubMed ID: 31794632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
    He J; Zhang W; Li F; Yu Y
    Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
    Jiang J; Bi Y; Liu XP; Yu D; Yan X; Yao J; Liu T; Li S
    J Cell Mol Med; 2020 May; 24(9):5375-5386. PubMed ID: 32233022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.